Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 16, 2015

Drug Name Review Type Class Manufacturer
Praluent New Drug Initial Review Cholesterol Lowering Sanofi
Daklinza New Drug Initial Review Hepatitis C Bristol-Myers Squibb
Cosentyx New Drug Initial Review Psoriasis Novartis
Feraheme New Drug Initial Review Intravenous Iron Amag
Technivie New Drug Initial Review Hepatitis C AbbVie
Corlanor New Drug Initial Review Heart Failure Amgen
Triumeq New Drug Initial Review HIV ViiV Healthcare
Entresto New Drug Initial Review Chronic Heart Failure Novartis
Invega Trinza New Drug Initial Review Atypical Antipsychotic Janssen Pharmaceuticals